Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis
Valentina Ghirardi(Agostino Gemelli University Polyclinic), Anna Fagotti(Università Cattolica del Sacro Cuore), Maria Cristina Moruzzi(Agostino Gemelli University Polyclinic), Virginia Vargiu(Agostino Gemelli University Polyclinic), Nicolò Bizzarri(Agostino Gemelli University Polyclinic), Tina Pasciuto(Agostino Gemelli University Polyclinic), Matteo Loverro(Agostino Gemelli University Polyclinic), Marco D’Indinosante(Agostino Gemelli University Polyclinic), Giorgia Garganese(Università Cattolica del Sacro Cuore), Giovanni Scambia(Agostino Gemelli University Polyclinic)
Cited by 39
Related Papers
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer
|International Journal of Gynecological Cancer|2020|298
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277
Uterine serous carcinoma
|Gynecologic Oncology|2021|158